Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath

评估电子烟预防计划的中学集群随机对照试验:CATCH My Breath

基本信息

项目摘要

PROJECT SUMMARY / ABSTRACT The goal of this research is to empirically assess the three year effects of the ‘CATCH My Breath’ (CMB) program on delaying the onset of e-cigarette use with a 6th–8th grade cohort, using a 20-school group randomized controlled trial (RCT), with 1,400 students. E-cigarettes have grown in popularity and are the most commonly used tobacco product by US youth. Based on 2017 Monitoring the Future estimates, we project that 1.6 million middle school students will have ever tried an e-cigarette. Flavors such as candy and fruit are appealing to youth and play an important role in encouraging nonsmokers (and smokers) to try them. Although e-cigarettes are less harmful compared to combustible tobacco use, they contain nicotine, which is highly addictive. Recent research, including a 2017 meta analysis, strongly suggests that youth who only smoke e-cigarettes exhibit symptoms of addiction, and over time, are more likely to experiment with and use combustible tobacco. To avoid the possibility of nicotine addiction, nonsmoking youth should be educated about this health threat and discouraged from experimenting with e-cigarettes. Unfortunately, few e-cigarette prevention programs exist, and none tested for long-term efficacy. In addition, although some tobacco prevention programs have included an e-cigarette component, to our knowledge, none of these revised programs have been formally evaluated. The lack of e-cigarette specific program content, and rigorous evaluation, warrants the proposed project. CMB was developed and custom built with input from school administrators, health education coordinators, tobacco prevention educators, classroom teachers, students, and parents. CMB has been formatively evaluated and pilot tested at 59 middle schools in 7 states, resulting in positive feedback from over 100 middle school teachers and 9,578 6th–8th grade students. Our second pilot test was a pretest-posttest controlled experiment (2017-2018), and resulted in an treatment-control difference of 3.8% in ever smoking over a 16-month period. Finally, the research team, with the CATCH Global Foundation, have developed a digital school-health program distribution framework which includes in-person or on-line teacher training (https://catchinfo.org/modules/e- cigarettes/). Using this framework, CMB can be delivered to teachers at very low cost, eliminating cost and access to program materials as major barriers to program implementation. Given CMB’s current popularity with schools as a ‘best practice’ program, and with initial positive results, a full scale randomized control trial is needed to determine longer term, 6th-8th grade efficacy.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Harold Kelder其他文献

Steven Harold Kelder的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Harold Kelder', 18)}}的其他基金

Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath
评估电子烟预防计划的中学集群随机对照试验:CATCH My Breath
  • 批准号:
    10153732
  • 财政年份:
    2019
  • 资助金额:
    $ 62.37万
  • 项目类别:
Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath
评估电子烟预防计划的中学集群随机对照试验:CATCH My Breath
  • 批准号:
    9927611
  • 财政年份:
    2019
  • 资助金额:
    $ 62.37万
  • 项目类别:
Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath
评估电子烟预防计划的中学集群随机对照试验:CATCH My Breath
  • 批准号:
    10395478
  • 财政年份:
    2019
  • 资助金额:
    $ 62.37万
  • 项目类别:
Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath
评估电子烟预防计划的中学集群随机对照试验:CATCH My Breath
  • 批准号:
    10604262
  • 财政年份:
    2019
  • 资助金额:
    $ 62.37万
  • 项目类别:
SOUTH TEXAS PARENT DIABETES PREVENTION TRAIL (STPDPT)
南德克萨斯州家长糖尿病预防追踪 (STPDPT)
  • 批准号:
    7787022
  • 财政年份:
    2009
  • 资助金额:
    $ 62.37万
  • 项目类别:
SOUTH TEXAS PARENT DIABETES PREVENTION TRAIL (STPDPT)
南德克萨斯州家长糖尿病预防追踪 (STPDPT)
  • 批准号:
    7305022
  • 财政年份:
    2008
  • 资助金额:
    $ 62.37万
  • 项目类别:
Health, Education and Discovering Science and Careers
健康、教育、探索科学和职业
  • 批准号:
    7480384
  • 财政年份:
    2004
  • 资助金额:
    $ 62.37万
  • 项目类别:
Core--Cardiovascular Disease
核心--心血管疾病
  • 批准号:
    6726459
  • 财政年份:
    2003
  • 资助金额:
    $ 62.37万
  • 项目类别:
TEXAS CATCH PHASE III--TRACKING FIELD CENTER
德克萨斯州捕获第三期--追踪场地中心
  • 批准号:
    2028364
  • 财政年份:
    1987
  • 资助金额:
    $ 62.37万
  • 项目类别:
Core--Cardiovascular Disease
核心--心血管疾病
  • 批准号:
    7525178
  • 财政年份:
  • 资助金额:
    $ 62.37万
  • 项目类别:

相似海外基金

Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
  • 批准号:
    10712647
  • 财政年份:
    2001
  • 资助金额:
    $ 62.37万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    6247642
  • 财政年份:
    1997
  • 资助金额:
    $ 62.37万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    3718999
  • 财政年份:
  • 资助金额:
    $ 62.37万
  • 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
  • 批准号:
    465668867
  • 财政年份:
  • 资助金额:
    $ 62.37万
  • 项目类别:
    Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
  • 批准号:
    3719026
  • 财政年份:
  • 资助金额:
    $ 62.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了